×
More Charts Below
Intelligent Bio Solutions Total Liabilities and Share Holders Equity 2020-2024 | INBS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Recent Trends
Intelligent Bio Solutions total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$133.5B
Elevance Health (ELV)
$96.1B
CVS Health (CVS)
$84.8B
Cencora (COR)
$55.6B
DiDi Global (DIDIY)
$20.3B
Natera (NTRA)
$20B
BioMerieux (BMXMF)
$15.6B
Solventum (SOLV)
$11.5B
ICON (ICLR)
$11.3B
EUROFINS SCIENT (ERFSF)
$11.1B
Revvity (RVTY)
$11B
CochLear (CHEOY)
$10.9B
Avantor (AVTR)
$10.3B
Doximity (DOCS)
$9.9B
Viatris (VTRS)
$9B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.3B
Charles River Laboratories (CRL)
$5.2B
Amplifon S.p.A (AMFPF)
$4.3B
Bausch + Lomb (BLCO)
$4.3B
Alignment Healthcare (ALHC)
$3.5B
Sotera Health (SHC)
$3B
BrightSpring Health Services (BTSG)
$2.9B
Organon (OGN)
$2.9B
Surgery Partners (SGRY)
$2.7B
GeneDx Holdings (WGS)
$2.7B
Concentras Parent (CON)
$2.6B
Progyny (PGNY)
$1.8B
Ardent Health Partners (ARDT)
$1.8B